Open AccessCombined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer
Author(s) -
A. Deal,
M.B. Siegel,
M.J. Sambade,
G.L. Johnson,
B.T. Golitz,
A.E.D. Van Swearingen,
Xuefeng Chen,
L. Mounsey,
S. Sud,
R.E. Bash,
C.R. Miller,
C. Santos,
S.M. Bevill,
Nadia Rashid,
Riley McNeill,
J.S. Parker,
C.K. Anders
Publication year - 2021
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/4qn4-n797
Subject(s) - triple negative breast cancer , breast cancer , cancer research , medicine , kinase , pi3k/akt/mtor pathway , triple negative , oncology , cancer , chemistry , biochemistry , signal transduction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom